Peter Wijngaard
Net worth: 1 531 $ as of 2024-06-29
Career history of Peter Wijngaard
Former positions of Peter Wijngaard
| Companies | Position | Start | End |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 2020-06-09 | 2023-12-03 |
| Independent Dir/Board Member | 2020-06-09 | 2023-12-03 | |
| The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | - | 2019-12-31 |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Director/Board Member | 2014-02-28 | 2016-05-31 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Director/Board Member | 2011-01-31 | 2013-10-22 |
| Independent Dir/Board Member | 2011-01-31 | 2013-10-22 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director/Board Member | - | - |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 2013-10-24 | - |
| Chairman | 2011-02-17 | 2013-10-24 | |
| Independent Dir/Board Member | 2011-02-17 | - |
Training of Peter Wijngaard
| University of Utrecht | Doctorate Degree |
Statistics
International
| United States | 4 |
| Canada | 3 |
| Netherlands | 2 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
| The Medicines Company (Schweiz) GmbH | |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- Peter Wijngaard
- Experience
